Search clinical trials for: ZOSTAVAX™

Total 3703 results

Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)

Shingles
Merck Sharp & Dohme LLC

Completed

Study to Evaluate Immunogenicity, Safety, and Tolerability of ZOSTAVAX™ Vaccine (Zoster Vaccine Live, V211) Administered Concomitantly Versus Nonconcomitantly With Quadrivalent Influenza Virus Vaccine (Inactivated) in Participants ≥50 Years of Age (V211-062)

Herpes Zoster
Merck Sharp & Dohme LLC

Completed

A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)

Herpes Zoster
Merck Sharp & Dohme LLC

Completed

A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)

Herpes Zoster
Merck Sharp & Dohme LLC

Completed

A Study of Intradermal Administration of ZOSTAVAX™ (V211-051 AM2)

Herpes Zoster
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)

Herpes Zoster | Shingles
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)

Herpes Zoster | Shingles
Merck Sharp & Dohme LLC
University of Colorado, Denver; Duke University

Completed

Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)

Herpes Zoster | Varicella-zoster Vaccine
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)

Herpes Zoster | Pneumococcal Infection
Merck Sharp & Dohme LLC
Kaiser Permanente

Completed

ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)

Herpes Zoster | Shingles
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020

Herpes Zoster

United States
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety Study of ZOSTAVAX Administered by Intramuscular or Subcutaneous Route to Participants Aged From 50 Years Old (V211-045)

Herpes Zoster
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)

Herpes Zoster | Shingles
University of Zurich

Withdrawn

Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-Study

Herpes Zoster
University of Sydney

Completed

Herpes Zoster Vaccine for Bone Marrow Transplant Donors (VZV-Zostavax)

Herpes Zoster

Australia
Seoul National University Hospital

Completed

Optimal Timing of Zoster Vaccine After Hematopoietic Stem Cell Transplantation

Herpes Zoster

Korea, Republic of
Seoul National University Hospital

Completed

Optimal Timing of Zoster Vaccine After Zoster Illness

Shingles

Korea, Republic of
University of Colorado, Denver
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Persistence of Protection by Shingrix

Herpes Zoster

United States
University of South Florida
Merck Sharp & Dohme LLC

Terminated

Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older

X-linked Agammaglobulinemia | Specific Antibody Deficiency | Common Variable Immune Deficiency

United States
SK Chemicals Co., Ltd.

Completed

Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

Herpes Zoster

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

Herpes Zoster

Korea, Republic of
Oklahoma Medical Research Foundation

Completed

Zostavax in Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States
Merck Sharp & Dohme LLC

Completed

Zostavax® at Minimum Release Specification Approaching Expiry (V211-044)

Herpes Zoster
Tuen Mun Hospital

Completed

Safety and Immunogenicity of a Zoster Vaccine in SLE

Systemic Lupus Erythematosus

China
The University of Hong Kong

Completed

VZV Vaccine for Hematopoietic Stem Cell Transplantation (VZIDST)

Varicella Zoster Infection

Hong Kong
HaEmek Medical Center, Israel

Unknown

Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic Patients

Herpes Zoster

Israel
University of Alberta

Completed

Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation

Kidney Transplant

Canada
Rockefeller University
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination

Hepatitis C

United States
University of Washington
Merck Sharp & Dohme LLC

Completed

Immune Response to Shingles Vaccination

Shingles

United States
SK Chemicals Co., Ltd.

Completed

Safety Study of NBP608 in Healthy Adult Volunteers

Immunization; Infection | Varicella Zoster

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)

Herpes Zoster
National Institute of Allergy and Infectious Diseases...
Merck Sharp & Dohme LLC; Adult AIDS Clinical Trials Group

Completed

Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy

HIV Infections | Herpes Zoster

United States
Merck Sharp & Dohme LLC

Completed

ZOSTAVAX(R) Local Registration Trial (V211-019)

Varicella Virus Infection
Oklahoma Medical Research Foundation

Completed

Safety of Zostavax Vaccination in Rheumatoid Arthritis

Rheumatoid Arthritis | Varicella Zoster

United States
University of Alabama at Birmingham
Oregon Health and Science University

Completed

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

Arthritis | Rheumatoid Arthritis | Psoriasis | Crohn's Disease | Inflammatory Arthritis | Psoriatic Arthritis | Ankylosing Spondylitis | Enteropathic Arthritis

United States
Innovaderm Research Inc.
Merck Sharp & Dohme LLC

Terminated

Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy

Psoriasis

Canada
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Systems Biology of Zoster Vaccine (ZOSTAVAX®) in Young and Elderly

Shingles

United States
University of Colorado, Denver
Merck Sharp & Dohme LLC; National Institute on Aging (NIA)

Completed

Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents

Immunosenescence | Shingles

United States
McMaster University
Merck Sharp & Dohme LLC

Completed

Zoster Vaccine Response in the Frail Elderly

Immune System Diseases

Canada
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043)

Prevention of : Herpes-Zoster
Louis Stokes VA Medical Center
Duke University

Unknown

ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors

Shingles
Tulane University

Completed

Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™

Fibrosis | Herpes Zoster
University of Colorado, Denver
GlaxoSmithKline

Completed

Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds

Herpes Zoster | Shingles

United States
BaroNova, Inc.

Completed

A Study of the TransPyloric Shuttle™ (TPS™) for Weight Reduction in Obese Subjects

Obesity

Australia
London Health Sciences Centre
University of Western Ontario, Canada; Synaptive Medical

Unknown

DTI & Tractography in Pediatric Tumor Surgery

Brain Damage, Chronic | Cerebellar Cognitive Affective Syndrome | Cerebellar Mutism
Asklepios Kliniken Hamburg GmbH
University of Kiel

Completed

A Comparison of the Intubating Laryngeal Mask FASTRACH™ and the Intubating Laryngeal Mask Ambu Aura-i™

Airway Management | Laryngeal Mask Airway | Fibreoptic Intubation
Andrew Parrent
University of Western Ontario, Canada; Synaptive Medical

Unknown

Application of Diffusion Tensor Imaging and Tractography in Epilepsy Surgery

Temporal Lobe Epilepsy
CereVasc Inc
AlvaMed, Inc.; Simplified Clinical Data Systems, LLC; Bioscience Consulting,...

Recruiting

The ETCHES I Study (Endovascular Treatment of Communicating Hydrocephalus With an Endovascular Shunt) (ETCHES I)

Hydrocephalus | Hydrocephalus, Communicating

Argentina
Medtronic Cardiovascular

Active, not recruiting

ANCHOR (Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System Global Registry) (ANCHOR)

Aortic Aneurysm

Germany, New Zealand, United States, Netherlands, Switzerland, United Kingdom, Spain, Australia, Italy, Sweden, France, Austria, Slovakia
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine

Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b

Korea, Republic of

Search clinical trials for: ZOSTAVAX™

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations